{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:11:38Z","timestamp":1786119098354,"version":"build-2736575974"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Cytomegalovirus (CMV) disease is a rare but significant complication among nontransplant pediatric leukemia patients. CMV infection has been observed in patients receiving tyrosine kinase inhibitors (TKIs) indicated for the treatment of chronic myeloid leukemia (CML), Philadelphia chromosome-positive (Ph+), and Philadelphia chromosome-like (Ph-like) acute lymphoblastic leukemia (ALL). However, there is limited published data regarding CMV disease in nontransplant leukemia patients treated with TKIs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Observations:<\/jats:title>\n                    <jats:p>We present 2 cases of severe CMV disease in Ph+ and Ph-like ALL patients treated with TKI plus chemotherapy without transplant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>We highlight this uncommon but serious adverse event in the pediatric population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mph.0000000000003193","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T21:00:13Z","timestamp":1774645213000},"page":"201-206","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Two Cases of Severe Cytomegalovirus Disease in Nontransplant Pediatric Acute Lymphoblastic Leukemia Patients Treated With Tyrosine Kinase Inhibitors"],"prefix":"10.1097","volume":"48","author":[{"given":"Irvin","family":"Yi","sequence":"first","affiliation":[{"name":"Yale School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Foley","sequence":"additional","affiliation":[{"name":"Yale School of Medicine"},{"name":"Department of Pediatrics, Section of Hematology\/Oncology, Yale University, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aron","family":"Flagg","sequence":"additional","affiliation":[{"name":"Yale School of Medicine"},{"name":"Department of Pediatrics, Section of Hematology\/Oncology, Yale University, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Massaro","sequence":"additional","affiliation":[{"name":"Yale School of Medicine"},{"name":"Department of Pediatrics, Section of Hematology\/Oncology, Yale University, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0697-6871","authenticated-orcid":false,"given":"Daniel","family":"Prior","sequence":"additional","affiliation":[{"name":"Yale School of Medicine"},{"name":"Department of Pediatrics, Section of Hematology\/Oncology, Yale University, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"key":"R1-20260423","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.bbmt.2016.04.004","article-title":"Cytomegalovirus infection in pediatric hematopoietic stem cell transplantation: risk factors for primary infection and cases of recurrent and late infection at a single center","volume":"22","author":"Rowe","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"R2-20260423","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3389\/fcimb.2020.00130","article-title":"Cytomegalovirus latency and reactivation: an intricate interplay with the host immune response","volume":"10","author":"Forte","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"R3-20260423","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.hoc.2010.11.011","article-title":"Cytomegalovirus in hematopoietic stem cell transplant recipients","volume":"25","author":"Ljungman","year":"2011","journal-title":"Hematol Oncol Clin North Am"},{"key":"R4-20260423","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1093\/jpids\/piab041","article-title":"Incidence of CMV infection and disease and adverse events associated with antiviral therapy in a retrospective cohort of allogeneic hematopoietic cell transplant recipients at an Academic Children\u2019s Hospital","volume":"10","author":"Hayes","year":"2021","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R5-20260423","doi-asserted-by":"crossref","first-page":"ofab639","DOI":"10.1093\/ofid\/ofab639","article-title":"Risk factors for CMV viremia and treatment-associated adverse events among pediatric hematopoietic stem cell transplant recipients","volume":"9","author":"Heston","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"R6-20260423","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1128\/JCM.01670-06","article-title":"Epidemiologic analysis of reactivated cytomegalovirus antigenemia in patients with cancer","volume":"45","author":"Han","year":"2007","journal-title":"J Clin Microbiol"},{"key":"R7-20260423","doi-asserted-by":"crossref","first-page":"e14256","DOI":"10.1097\/MD.0000000000014256","article-title":"Monitoring of cytomegalovirus infection in non-transplant pediatric acute lymphoblastic leukemia patients during chemotherapy","volume":"98","author":"Phasuk","year":"2019","journal-title":"Medicine"},{"key":"R8-20260423","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/MPH.0000000000000298","article-title":"Cytomegalovirus disease in children with acute lymphoblastic leukemia in the nontransplant setting: case series and review of the literature","volume":"37","author":"Rahbarimanesh","year":"2015","journal-title":"J Pediatr Hematol Oncol"},{"key":"R9-20260423","doi-asserted-by":"crossref","first-page":"e510","DOI":"10.1016\/S2352-3026(23)00088-1","article-title":"Dasatinib with intensive chemotherapy in de novo paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (CA180-372\/COG AALL1122): a single-arm, multicentre, phase 2 trial","volume":"10","author":"Hunger","year":"2023","journal-title":"Lancet Haematol"},{"key":"R10-20260423","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.clml.2025.05.013","article-title":"A Phase I\/II trial of ruxolitinib with chemotherapy for patients with relapsed and\/or refractory Philadelphia-like acute lymphoblastic leukemia","volume":"25","author":"Goulart","year":"2025","journal-title":"Clin Lymphoma Myeloma Leukemia"},{"issue":"suppl 1","key":"R11-20260423","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood-2018-99-110221","article-title":"A phase 2 study of ruxolitinib with chemotherapy in children with Philadelphia chromosome-like acute lymphoblastic leukemia (INCB18424-269\/AALL1521): dose-finding results from the part 1 safety phase","volume":"132","author":"Tasian","year":"2018","journal-title":"Blood"},{"key":"R12-20260423","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s15010-017-1105-1","article-title":"Infections in patients on BCR-ABL tyrosine kinase inhibitor therapy: cases and review of the literature","volume":"46","author":"Knoll","year":"2018","journal-title":"Infection"},{"key":"R13-20260423","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/ped.13251","article-title":"Cytomegalovirus infection- and dasatinib-induced proteinuria in Ph+ALL","volume":"59","author":"Kawaguchi","year":"2017","journal-title":"Pediatr Int"},{"key":"R14-20260423","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4137\/CCRep.S25327","article-title":"Cytomegalovirus-induced hemorrhagic colitis in a patient with chronic myeloid leukemia (Chronic Phase) on dasatinib as an upfront therapy","volume":"8","author":"Yassin","year":"2015","journal-title":"Clin Med Insights Case Rep"},{"key":"R15-20260423","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJMc1413918","article-title":"Cytomegalovirus retinitis in a patient who received ruxolitinib","volume":"374","author":"Hofsten","year":"2016","journal-title":"N Engl J Med"},{"key":"R16-20260423","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.bbmt.2019.04.003","article-title":"Efficacy, toxicity, and infectious complications in ruxolitinib-treated patients with corticosteroid-refractory graft-versus-host disease after hematopoietic cell transplantation","volume":"25","author":"Abedin","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"R17-20260423","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1200\/JCO.19.02892","article-title":"Impact of intrathecal triple therapy versus intrathecal methotrexate on disease-free survival for high-risk B-lymphoblastic leukemia: Children\u2019s Oncology Group Study AALL1131","volume":"38","author":"Salzer","year":"2020","journal-title":"J Clin Oncol"},{"key":"R18-20260423","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/cid\/cix325","article-title":"Dasatinib use and risk of cytomegalovirus reactivation after allogeneic hematopoietic-cell transplantation","volume":"65","author":"Prestes","year":"2017","journal-title":"Clin Infect Dis"},{"key":"R19-20260423","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.3109\/10428194.2013.854887","article-title":"Cytomegalovirus retinitis in children and young adults with acute lymphoblastic leukemia in Lebanon","volume":"55","author":"Samia","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"R20-20260423","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/pbc.24298","article-title":"Cytomegalovirus retinitis as an adverse immunological effect of pulses of vincristine and dexamethasone in maintenance therapy for childhood acute lymphoblastic leukemia","volume":"60","author":"Moritake","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"R21-20260423","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1442-200X.2011.03429.x","article-title":"Retinitis from cytomegalovirus during maintenance treatment for acute lymphoblastic leukemia","volume":"54","author":"Kobayashi","year":"2012","journal-title":"Pediatr Int"},{"key":"R22-20260423","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/MPH.0b013e318279e920","article-title":"Cytomegalovirus retinitis during maintenance therapy for T-cell acute lymphoblastic leukemia","volume":"35","author":"Wakai","year":"2013","journal-title":"J Pediatr Hematol Oncol"},{"key":"R23-20260423","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/pbc.22064","article-title":"Pediatric acute lymphoblastic leukemia complicated by secondary hemophagocytic lymphohistiocytosis","volume":"53","author":"Devecioglu","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"R24-20260423","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1097\/MPH.0b013e31827078ad","article-title":"Cytomegalovirus retinitis in an ALL child on exclusive chemotherapy treated successfully with intravitreal ganciclovir alone","volume":"35","author":"Singh","year":"2013","journal-title":"J Pediatr Hematol Oncol"},{"key":"R25-20260423","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0002-9394(99)00031-8","article-title":"Cytomegalovirus retinitis in immunosuppressed children","volume":"127","author":"Baumal","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"R26-20260423","first-page":"e32936","article-title":"Cytomegalovirus reactivation in patients with acute lymphoblastic leukemia in non-transplant setting","volume":"14","author":"Abbas","year":"2022","journal-title":"Cureus"},{"key":"R27-20260423","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/MPH.0000000000001547","article-title":"How to treat cytomegalovirus-induced hemophagocytic lymphohistiocytosis in a child with leukemia","volume":"42","author":"Eldem","year":"2020","journal-title":"J Pediatr Hematol Oncol"},{"key":"R28-20260423","doi-asserted-by":"crossref","first-page":"250","DOI":"10.4103\/ojo.OJO_190_2016","article-title":"Treatment of unilateral zone I cytomegalovirus retinitis in acute lymphoblastic leukemia with oral valganciclovir and intravitreal ganciclovir","volume":"10","author":"Tripathy","year":"2017","journal-title":"Oman J Ophthalmol"},{"key":"R29-20260423","doi-asserted-by":"crossref","first-page":"e935","DOI":"10.1097\/MPH.0000000000002272","article-title":"Is monitoring of cytomegalovirus disease required in nontransplant pediatric acute lymphoblastic leukemia?","volume":"43","author":"\u015een","year":"2021","journal-title":"J Pediatr Hematol Oncol"},{"key":"R30-20260423","doi-asserted-by":"crossref","first-page":"107005","DOI":"10.1016\/j.leukres.2022.107005","article-title":"Ruxolitinib-induced reactivation of cytomegalovirus and Epstein-Barr virus in graft-versus-host disease","volume":"125","author":"Lebon","year":"2023","journal-title":"Leuk Res"},{"key":"R31-20260423","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/hon.2769","article-title":"Impaired virus-specific T cell responses in patients with myeloproliferative neoplasms treated with ruxolitinib","volume":"38","author":"Rumi","year":"2020","journal-title":"Hematol Oncol"},{"key":"R32-20260423","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1002\/ijc.25233","article-title":"The BCR\/ABL-inhibitors imatinib, nilotinib and dasatinib differentially affect NK cell reactivity","volume":"127","author":"Salih","year":"2010","journal-title":"Int J Cancer"},{"key":"R33-20260423","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1179\/102453308X316086","article-title":"Immune reconstitution during maintenance therapy in children with acute lymphoblastic leukemia, relation to co-existing infection","volume":"13","author":"El-Chennawi","year":"2008","journal-title":"Hematology"},{"key":"R34-20260423","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1056\/NEJMra1400972","article-title":"Acute lymphoblastic leukemia in children","volume":"373","author":"Hunger","year":"2015","journal-title":"N Engl J Med"},{"key":"R35-20260423","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/cid\/ciae535","article-title":"Current and future strategies for the prevention and treatment of cytomegalovirus infections in transplantation","volume":"81","author":"Heldman","year":"2025","journal-title":"Clin Infect Dis"},{"key":"R36-20260423","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41409-021-01499-0","article-title":"Cytomegalovirus (CMV)-specific cytotoxic T lymphocyte therapy resolve CMV diseases and refractory CMV infections in paediatric recipients of allogeneic haematopoietic stem cell transplantation","volume":"57","author":"Wang","year":"2022","journal-title":"Bone Marrow Transplant"},{"key":"R37-20260423","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1182\/blood.2022015956","article-title":"T-cell exhaustion induced by continuous bispecific molecule exposure is ameliorated by treatment-free intervals","volume":"140","author":"Philipp","year":"2022","journal-title":"Blood"},{"key":"R38-20260423","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1056\/NEJMoa2016272","article-title":"Dasatinib-blinatumomab for Ph-positive acute lymphoblastic leukemia in adults","volume":"383","author":"Fo\u00e0","year":"2020","journal-title":"N Engl J Med"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MPH.0000000000003193","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:30:20Z","timestamp":1786037420000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MPH.0000000000003193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000003193","relation":{},"ISSN":["1077-4114","1536-3678"],"issn-type":[{"value":"1077-4114","type":"print"},{"value":"1536-3678","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,20]]},"assertion":[{"value":"2025-11-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-02","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}